title: Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma.
authors: Amer
authors: A
authors: Zeidan
authors: Javier
authors: J
authors: Bolaños-Meade
authors: Yvette
authors: Y
authors: Kasamon
authors: Joseph
authors: J
authors: Aoki
authors: Michael
authors: M
authors: Borowitz
authors: Lode
authors: L
authors: Swinnen
authors: Heather
authors: H
authors: Symons
authors: Leo
authors: L
authors: Luznik
authors: Ephraim
authors: E
authors: Fuchs
authors: Richard
authors: R
authors: Jones
authors: Richard
authors: R
authors: Ambinder
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D006086:Graft vs Host Disease / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D054747:Histiocytic Sarcoma / Q000276:immunology / Q000601:surgery*; D006648:Histocompatibility / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D016879:Salvage Therapy / Q000379:methods; D019172:Transplantation Conditioning / Q000379:methods; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D006680:HLA Antigens; D000074323:Alemtuzumab; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine